anxiety symptoms experienced during withdrawal. 14, [25] [26] [27] In general, depression and anxiety are risk factors for poor adherence to recommended preventative behaviors, 28 including quitting smoking. Furthermore, few studies have specifically examined factors predictive of dropout from smoking cessation programs. In general, studies have long observation periods, but it is important to identify early which smokers are more likely to remain engaged in treatment. We consider that it is important to understand the personal characteristics that favor or negatively impact on adherence to smoking cessation treatment, because this insight should help with development of practices that can promote engagement and, consequently, improve support group effectiveness. The objective of this study was therefore to determine whether people who were adherent to a smoking cessation support group, i.e. those who attended the meetings, had different characteristics to those who were non-adherent, in terms of demographic variables, smoking history, presence of tobacco-related diseases, severity of nicotine dependence, motivation stage, and symptoms of anxiety and depression.
Methods

Participants
The study participants were male and female smokers aged 18 or over and living in Porto Alegre, Brazil. Smokers were recruited from the community by newspaper and radio advertisements publicizing a support group for smoking cessation. People who were interested called a call-center for drug abuse prevention and were given a description of how the group sessions would be conducted and participation in a group was then scheduled if the smoker chose to participate. The people enrolled were current cigarette smokers who presented on the date scheduled.
Smokers under 18 years of age or those who reported current illicit drugs use, nicotine replacement therapy, bupropion treatment, or the presence of debilitating conditions that could interfere with group participation were excluded. Table 1 contains the characteristics of the 166 smokers who participated in the study.
Introduction
There are nearly 22 million smokers in Brazil and 15% of the population aged 15 years or over smokes.
Almost 44% of male current smokers and 53% of female current smokers have tried to quit smoking in the past 12 months, 1 but only 15.2% and 6.7% did so, with the help of counseling or pharmacotherapy respectively. 2 Cognitivebehavioral therapy plus medication is the treatment method for smoking cessation. However, pharmacotherapy is overvalued and there is minimal emphasis on unassisted cessation or behavioral treatment. 3 Since pharmacotherapy is prohibitively expensive for low-income populations, it is of interest to be able to predict which smokers would continue attending behavioral treatment alone, in order to initially invest in this approach with those individuals.
Moreover, group behavior programs for smoking cessation may be economically more attractive because smokers can be given more counseling time and more people can be treated by a single professional simultaneously. 4 This is particularly important in Brazil, since the available resources are insufficient to provide care for all those who need it, despite increasing efforts to provide smokers with treatment. 2, 5 To effectively assist larger numbers of smokers with a group approach would lead to a reduction in costs for public health administrations, allowing application of financial resources to purchase more medications for those smokers who really need them to quit.
However, even in trials in which smokers have agreed to attend treatment meetings, the non-participation rate is often high. Adherence is patient acceptance of recommended health behaviors, such as taking medication, adopting a proposed diet, or changing lifestyle habits 6 and proves a challenge for health professionals.
Generally, higher levels of adherence to medical treatment are associated with better health outcomes and with public health cost reductions. [7] [8] [9] [10] However, it is difficult to compare findings on adherence, because the term can have different meanings; ranging from merely participating (sometimes termed retention), to actually following the proposed regimen until the desired outcome is achieved. 11 Higher adherence to smoking treatment is associated with a higher chance of nicotine abstinence and higher latency to relapse. 12, 13 Average rates of adherence to multiple sessions of behavioral smoking cessation treatments range from 30 to 66%. [14] [15] [16] [17] [18] [19] In Brazil, the rate of adherence to group intervention for smoking cessation varies from 67 to 95%. [20] [21] [22] [23] 
Sampling
Sampling was by convenience in this study. The sample size was calculated, based on an adherence rate of 55%, observed during the first month of a group intervention for smoking cessation, 17 to find a relative difference between actual and estimated the proportion of no more than 15%, at α = 0.05. After addition of 20% to allow for losses, the sample size calculated corresponded to 162 people.
Study design
Longitudinal study in two periods (second and fourth session).
Measures Sociodemographic characteristics
The questionnaire included questions on gender, age, marital status, occupation, family income, education level, reported tobacco-related diseases (diabetes, hypertension, cancer, and respiratory and cardiovascular diseases) and use of medication, alcohol, or illicit drugs.
Smoking history
Smoking history was evaluated using a questionnaire covering the age at which respondents started smoking, number of cigarettes smoked per day, years smoking, number of previous attempts to quit smoking, and the longest previous period of abstinence from smoking.
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Nicotine dependence
Dependence was diagnosed on the basis of assessment with the Brazilian National Household Survey on Drug Abuse, a measure which is based on the National Household Survey on Drug Abuse (NHSDA). 33, 34 This questionnaire covers six symptoms of the dependence syndrome: tolerance, lack of control over use, significant time spent in activities related to use, continued use of the substance despite the physical risks and personal problems resulting from use, and at least one unsuccessful attempt to stop or to decrease use. Smokers were considered dependent if they endorsed at least two of these criteria. 33 Intensity of nicotine dependence was measured using the Fagerström Test for Nicotine Dependence (FTND), a measure which consists of six questions related to smoking. 35, 36 This questionnaire classifies the level of dependence from very low to very high. The total score is calculated by adding the scores obtained for each question, which range from 0 to 10 points.
Motivational stage
Motivational stage was measured using the University of Rhode Island Change Assessment Scale (URICA) and the Contemplation Ladder. [37] [38] [39] The URICA assesses to what degree participants are willing to change their smoking behavior by indicating whether they agree or disagree with certain statements.
Responses are distributed along a Likert scale. Based on the answers, the scores can be equated to stages of precontemplation, contemplation, action, and maintenance, 40 and a total score can be calculated by adding the averages for the subscales of contemplation, action, and maintenance, and subtracting the mean for the precontemplation subscale. Motivation was defined as high when the total score was above 70%
of the maximum possible score. On the Contemplation Ladder, used in modified form, participants chose one statement from a group of five that best represented their thinking in relation to smoking at the time. The stage of readiness was classified as precontemplation, contemplation, preparation or action.
Symptoms of anxiety
The Beck Anxiety Inventory (BAI), a measure consisting of 21 items that describe various symptoms of anxiety, was used to assess the levels of symptoms of anxiety. Subjects mark the level of intensity at which they experience each symptom within a range of 0 to Moreover, this initial period represents a moment of great importance in the process of smoking cessation, since it has been shown that smokers are most likely to relapse in the first weeks of treatment.
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Data analyses
Statistical analysis was performed to determine whether sociodemographic characteristics, smoking history, knowledge of smoking-related diseases, motivational stage, and symptoms of depression and anxiety were associated with adherence to a program for smoking cessation. Associations between variables and outcomes were identified using the chi-square test.
Odds ratios and 95% confidence intervals were also used. Missing data were excluded analysis by analysis.
Variables which yielded significance or exhibited trends in associations (p < 0.2) were entered into a multivariate model to control for possible confounding variables. Tests were performed using PASW Statistics 18. Associations were considered significant for p < 0.05.
Results
In total, 183 smokers attended the first meeting. 23 were more likely to adhere to treatment.
The prevalence of depression is higher among should be valued because stopping smoking before the onset of smoking-related illness represents a gain in health for both the individual and for society.
It is generally assumed that heavy smokers would be more likely to seek expert care and to engage with it, 25, 45, 46, 50 because they recognize the level of difficulty they would face if they attempted to achieve abstinence by their own efforts. 47, 51 However, in the current study, the less the participants smoked the more likely they were to attend group sessions. Similarly, Asfar et al. 18 reported a trend towards an association between lower numbers of cigarettes smoked and greater adherence to face-to-face treatment. The lack of autonomy over smoking, that even smokers with low-rate consumption may develop, 52 may explain why cessation is difficult in this group and why they also seek and engage with specialized treatment.
Anxiety is a symptom that is commonly observed in tobacco withdrawal syndrome 53 and is considered a predictor of relapse. [54] [55] [56] The association between anxiety and adherence to treatment for smoking cessation has not been studied extensively, and our report has demonstrated that smokers with lower levels of anxiety showed higher final adherence to the program. Likewise, Kuhl et al. 57 concluded that anxiety was a predictor of poor adherence to smoking treatment in postmyocardial infarction patients. It may be the case that anxious smokers do not benefit fully from the group sessions because they may request special attention from the professional who leads the groups during the discussions. Furthermore, quitting smoking represents the loss of a control or of a coping mechanism for their anxiety and, for this reason, smokers with high levels of anxiety feel less able to stop due to increased symptoms of withdrawal. 54, 58 However, symptoms of anxiety did not influence the probability of maintaining abstinence among smokers attending individualized pharmacological therapy. 59 In another study, anxiety was only a predictor of failure to achieve abstinence among women. 60 Interestingly, different characteristics were associated with adherence at the two points during the program that were studied. From a theoretical point of view, adherence can be intentional or unintentional 11, 24 and it seems that age and number of cigarettes are associated with the intention and decision to abandon the treatment, while the symptoms of anxiety are negative and unintentionally discourage smokers from group therapy. 21 These individual sessions could also serve as screening interviews to avoid prescribing group treatment for people who will not adapt to this approach.
Biofeedback can also be an interesting strategy. Adding a clinical or biological marker of the consequences of tobacco use to group discussions could more strongly motivate smokers to seek to change this situation. This would add a measurable index to the subjective benefits of following the treatment.
Practitioners interested in maximizing adherence
could consider providing this treatment to specific groups of smokers. It is probable that adaptations to interventions are needed for less adherent smokers and possibly a proposal for group therapy with only these smokers should be considered. Moreover, it is also possible that these smokers need different approaches simultaneously.
The current study should be interpreted with some degree of caution. The sample was non-probabilistic and the subjects were enrolled in a clinical setting and therefore may not be representative of all smokers. The sample size was calculated based on an adherence rate that was higher than the rate actually observed in this study and so some of the results may not have been significant because of small sample size. Moreover, some participants who were lost to follow up may have stopped smoking and so not have perceived any utility in attending subsequent support group meetings. To the extent that this occurred, the findings may be biased toward understanding factors related to adherence among program participants who experience a negative program outcome (i.e., failure to achieve abstinence).
The lack of contact with dropouts is one limitation to this study. More conclusive results would be possible with a larger group of participants and a systematic investigation of the reasons individuals did not continue to attend the meetings.
Conclusion
Determination of predictors of adherence to programs for smoking cessation might provide scientific knowledge that could then be used to develop treatments tailored to improve the adherence of smokers and, consequently, the outcomes of interventions. Our results showed that older smokers and smokers who smoked fewer cigarettes per day had higher immediate adherence to the treatment and that smokers with lower levels of anxiety had higher final adherence to the treatment. One would imagine that these smokers have fewer complicating factors and so could achieve success with support groups alone.
Since there is a lack of access to pharmacotherapy in low investigate the influence of smokers' expectations on the efficacy of their attempts to quit.
It is known that group-based behavioral interventions are more effective than self-help materials, advice, or no intervention. 4, 75, 76 Furthermore, group treatments have similar efficacy and effectiveness to individual interventions for smoking cessation treatment.
4,17
However, despite the recognized efficacy of this approach, adherence to group programs remains a barrier to tobacco control; no more than 40 to 60% of the smokers who begin these treatments attend the meetings consistently, 23% of the participants leave treatment within the first month, and around 45% leave it within two months. 16, 17 In our study, adherence to the support group was even lower, with only one-third of the individuals attending all the meetings in one month. Poor adherence is also a problem in group treatment of other addictions; for example, only around 20% of alcoholics in
Brazil are still attending Alcoholics Anonymous meetings at six-month follow-up. 77 Comparing the approach used here with studies from other countries may prove disappointing, mainly due to intrinsic characteristics of the support groups in Brazil. Usually these treatments are provided by public health services 5 and recruitment is carried out reactively.
Moreover, patients' participation is not accompanied by any kind of incentive, principally financial incentives.
Therefore, the adherence rate to treatment solely reflects the individual patient's commitment to and engagement with the proposed scheme per se and, not surprisingly, is lower than rates found in international studies.
Despite the objective contained in Brazil's National Tobacco Control Plan to increase smokers' access to effective methods of smoking cessation, efforts are still insufficient: only 6.7% of smokers have tried to quit using pharmacotherapy, for example. 2 Since support groups are a central approach to smoking cessation in Brazil, it is important to know the predictors of adherence to support groups to be able to plan this treatment better.
Health professionals who deliver these interventions should be able to identify smokers at higher risk of nonengagement, even if they show interest in following the activities proposed in a first contact. Even smokers who adhere poorly to the support group may benefit from other strategies to increase their engagement with this treatment before referring them to drug treatment.
These people should receive special attentionphone calls, mobile phone messages, letters, and e-mails to remind them of upcoming meetings could help to improve attendance rates. It may also be possible to increase adherence to support groups by using initial sessions to administer motivational interventions designed to increase smokers' engagement with the resource situations, studying the performance of these smokers is a subject for further research.
